Blue Water Acquisition Corp. III operates as a blank check company. The company is headquartered in Greenwich, Connecticut. The company went IPO on 2025-06-10. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific Business Combination target, and the Company has not, nor has anyone on its behalf, engaged in any substantive discussions, directly or indirectly, with any Business Combination target. The firm neither engaged in any operations nor generated any revenue.
根据最新的财务报表(Form-10K),Blue Water Acquisition Corp III 的总资产为 $0,净损失为 $0
BLUWU 的关键财务比率是什么?
Blue Water Acquisition Corp III 的流动比率是 0,净利 margin 为 0,每股销售为 $0。
Blue Water Acquisition Corp III 的收入按细分市场或地理位置如何划分?
Blue Water Acquisition Corp III 最大收入来源是 Recombinant Human C1 Esterase Inhibitor,在最近的收益报告中收入为 226,910,050。就地区而言, United States 是 Blue Water Acquisition Corp III 的主要市场,收入为 221,166,908。
Blue Water Acquisition Corp III 是否盈利?
不,根据最新的财务报表,Blue Water Acquisition Corp III 的净损失为 $0